nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Burnout in the haematological workforce
|
The Lancet Haematology, |
|
|
10 |
7 |
p. e477 |
artikel |
2 |
Concerns on perioperative anaemia management in the FIT trial
|
Sato, Tomohiko |
|
|
10 |
7 |
p. e485-e486 |
artikel |
3 |
Concerns on perioperative anaemia management in the FIT trial
|
Petzer, Verena |
|
|
10 |
7 |
p. e485 |
artikel |
4 |
Correction to Lancet Haematol 2023; 10: e213–24
|
|
|
|
10 |
7 |
p. e490 |
artikel |
5 |
Correction to Lancet Haematol 2023; 10: e433–44
|
|
|
|
10 |
7 |
p. e490 |
artikel |
6 |
Correction to Lancet Haematol 2023; 10: e333–45
|
|
|
|
10 |
7 |
p. e490 |
artikel |
7 |
Could improving mental health disorders help increase cancer survival?
|
Davies, Elizabeth A |
|
|
10 |
7 |
p. e482-e484 |
artikel |
8 |
CPX-351 for higher risk myelodysplastic syndrome: cytarabine and daunorubicin in disguise?
|
Muus, Petra |
|
|
10 |
7 |
p. e481-e482 |
artikel |
9 |
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study
|
Peterlin, Pierre |
|
|
10 |
7 |
p. e521-e529 |
artikel |
10 |
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial
|
Hunger, Stephen P |
|
|
10 |
7 |
p. e510-e520 |
artikel |
11 |
Defibrotide prophylaxis for prevention of sinusoidal obstruction syndrome
|
Shibusawa, Motoharu |
|
|
10 |
7 |
p. e487-e488 |
artikel |
12 |
Defibrotide prophylaxis for prevention of sinusoidal obstruction syndrome
|
Halder, Rohan |
|
|
10 |
7 |
p. e487 |
artikel |
13 |
Defibrotide prophylaxis for prevention of sinusoidal obstruction syndrome – Authors' reply
|
Grupp, Stephan A |
|
|
10 |
7 |
p. e488-e489 |
artikel |
14 |
Inequalities in the career pathway for paediatric HSCT and cellular therapy physicians
|
Gurnari, Carmelo |
|
|
10 |
7 |
p. e492-e494 |
artikel |
15 |
Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma
|
O’Donnell, Jake S |
|
|
10 |
7 |
p. e539-e548 |
artikel |
16 |
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial
|
Döhner, Hartmut |
|
|
10 |
7 |
p. e495-e509 |
artikel |
17 |
Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study
|
Kuczmarski, Thomas M |
|
|
10 |
7 |
p. e530-e538 |
artikel |
18 |
Monoclonal B-cell lymphocytosis, monoclonal gammopathy of undetermined significance, and T-cell clones of uncertain significance: are these premalignant conditions sharing a common identity?
|
Semenzato, Gianpietro |
|
|
10 |
7 |
p. e549-e556 |
artikel |
19 |
More opportunities to advance paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia
|
Murphy, Lindsey |
|
|
10 |
7 |
p. e479-e481 |
artikel |
20 |
Oleksandr Lysytsia: the war in Ukraine has changed everything about our lives
|
Wilkinson, Emma |
|
|
10 |
7 |
p. e491 |
artikel |
21 |
The essential role of randomised controlled trials
|
Marini, Bernard L |
|
|
10 |
7 |
p. e486-e487 |
artikel |
22 |
Time to add gemtuzumab ozogamicin to intensive chemotherapy for NPM1-mutated acute myeloid leukaemia?
|
Othman, Jad |
|
|
10 |
7 |
p. e478-e479 |
artikel |